Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies - a EuroFlow study.
Verbeek MWC, Buracchi C, Laqua A, Nierkens S, Sedek L, Flores-Montero J, Hofmans M, Sobral de Costa E, Nováková M, Mejstrikova E, Barrena S, Kohlscheen S, Szczepanowski M, Kulis J, Oliveira E, Jugooa R, de Jong AX, Szczepanski T, Philippé J, van Dongen JJM, Orfao A, Brüggemann M, Gaipa G, van der Velden VHJ.
Verbeek MWC, et al. Among authors: van dongen jjm, van der velden vhj.
Br J Haematol. 2022 Apr;197(1):76-81. doi: 10.1111/bjh.17992. Epub 2021 Dec 8.
Br J Haematol. 2022.
PMID: 34881427
Free PMC article.